Skip to main content
Premium Trial:

Request an Annual Quote

Rosetta Receives NY State Clearance for Second-Gen Test for Cancer of Unknown Primary

Premium

Rosetta Genomics said this week that the New York State Department of Health has approved the company's miRview Mets 2 microRNA diagnostic, which is used to detect the source of cancers of unknown primary origin.

New York is the only state that requires an independent regulatory review for laboratory-developed tests, Rosetta noted.

With the approval, Rosetta said it can now market the test in all 50 US states.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.